136
Z. Ma et al. / Inorganica Chimica Acta 388 (2012) 135–139
presence of quinoline. It is worth noting that several examples of
Click reactions to modify metal–organic coordination complexes
or organometallic species have been reported in recent years
[20–23]. Single-crystal XRD, 1D, 2D NMR, and Diffusion Ordered
Spectroscopy (DOSY) [24,25] NMR were used to characterize these
coordination complexes in this work. In current study, DOSY and
Hirshfeld Surface Analyses were particularly used to investigate
the stability of coordination chromophore during PSM.
flask. Sodium ascorbate (25 mg, prepared 1 M solution in water) was
added and copper (II) sulfate pentahydrate (0.1 mmol, 25 mg, pre-
pared in water) was added sequentially while stirring. The mixture
was stirred vigorouslyovernight. Pale yellowsolid product 2 was ob-
tained by filtration and washed with cool water and ether for several
times, and then was dried under vacuum for several hours. Yield:
259 mg, 93.0%. IR (DMSO, 2500–1400 cmÀ1
) 1659.7, 1437.3,
1314.6 cmÀ1 1H NMR (DMSO-d6, 400 MHz): d 9.59, 8.13, 8.07,
.
3.9 ppm. 13C NMR (DMSO-d6, 400 MHz): d 160.98, 140.11, 138.20,
131.45, 127.85, 120.46, 52.49 ppm.
2. Experimental
2.2.1. Recrystallization of 2
2.1. Materials and methods
Zn(OOC–C6H4–C2HN3–COOCH3)2Á(quinoline)ÁDMSO (3): 20 mg
pale yellow zinc complex 2 was added in 14 ml mixture solution
of methanol, quinoline and DMSO (volume ratio 9:3:2). The mix-
ture was heated up to 90 °C until the solid was dissolved. The solu-
tion was allowed to slowly cool down to room temperature. Single
crystal did not form immediately after the solution was cooled
down. Pale yellow single crystals 3 were formed gradually in about
one week. Crystal data: CCDC 832827, ZnC33O9N7SH29, M = 765.06,
Zinc nitrate hexahydrate, solvents, 3-ethynylpridine and methyl
propiolate were purchased from Sigma Aldrich Co. Sodium 4-ethy-
nylbenzote was purchased from VWR international Inc, and 4-azi-
dobenzoic acid was purchased from TCI America. Deuterated
solvents were purchased from Cambridge Isotope Laboratory. All
the materials were used as received, without further purification.
Single-crystal X-ray diffraction data were collected on a BRU-
ꢀ
triclinic, P1, a = 7.8535(16) Å, b = 12.429(3) Å, c = 17.564(4) Å,
KER SMART-APEX CCD diffractometer using Mo K
a radiation
a
= 98.68(3), b = 100.40(3),
c
= 91.27(3). Z = 2, V = 1664.8(6) Å3, R
(k = 0.71073 Å). The structure was solved by direct methods and
refined by full-matrix least-squares refinement with anisotropic
displacement parameters for all non-hydrogen atoms. The hydro-
gen atoms were generated geometrically and included in the
refinement with fixed position and thermal parameters. IR spectra
were recorded on an ATI Mattson Infinity series FTIR instrument.
NMR experiments were recorded on either a Bruker DRX-300 with
a z-gradient BBI probe or Bruker DPX-400 with a z-gradient BBO
probe operating at 300.13 MHz and 400.13 MHz for 1H observe
respectively. DOSY spectra were acquired using the Bruker pulse
program ledbpgp2s for 2, using sinusoidal gradients with durations
between 1.25 and 3.5 ms. The gradient strength was varied be-
tween 2% and 95% in 128 increments for 2. Diffusion times of 70
to 80 ms were used for 2. DOSY spectra were processed using the
Bruker Topspin software with exponential line fitting.
values: (I > 2 (I)) R1 = 0.0659, wR2 = 0.1141; GOF = 0.928. Yield:
12 mg, 43.7 % (based on Zn).
r
3. Results and discussion
The postsynthetic modification of complex 1 in this work in-
cludes 2 steps: (1) the formation of an intermediate (complex 2)
via Click reaction and (2) recrystallization of complex 2 to form
the final product (complex II) with presence of quinoline (anicllary
ligand). The two-step PSM process is schematically shown in Fig. 1.
3.1. NMR characterizations of complexes 1 and 2
The 1H spectra of methyl propiolate, complex 1, and complex 2
are displayed in Fig. 2. Methyl propiolate was successfully ‘clicked’
with all the 4-azidobenzoate moieties on complex 1 to form 1-(4-
carboxyphenyl)-4-methoxycarbonyl-1,2,3-triazole (L) as evi-
denced by the disappearance of the acetylenic proton at
4.57 ppm, the persistence of the ester methyl resonance at
3.9 ppm, and the emergence of the new triazole proton at
ꢀ9.7 ppm. The 1H spectrum of 2 indicates that quinoline ligands
disappeared after the reaction. The loss of quinoline may be partly
related to the existence of Cu in the reaction mixture. All proton
and carbon assignments in Fig. 2 were based on HSQC and HMBC
NMR experiments (see Supporting information).
Single crystal molecular graphics were generated using Accelrys
MS Modeling v4.0. Hirshfeld surface graphics were generated using
CRYSTALEXPLORER 2.1, (2007) University of Western Australia [34].
2.2. Synthesis of the complexes
Note: Standard personal protective equipments including safety
glasses, lab coat, and gloves must be worn. Handle azide reactions
behind a blast shield in the fume hood. Do not combine untreated
aqueous or organic azide waste with other waste.
Zn2(OOC–C6H4–N3)4(quinoline)2
(1):
4-azidobenzoic
acid
(1 mmol, 163 mg) and zinc nitrate hexahydrate (0.5 mmol,
297 mg) were dissolved in 10 ml methanol, then 1 ml quinoline
was added into the solution. The solution was transferred to a
20 ml glass vial which was loosely capped and allowed to stand
for about a week. Colorless prismatic crystals (complex 1) were ob-
Complex 2 in DMSO was investigated by using Diffusion Or-
dered Spectroscopy NMR experiments. DOSY methods are based
on pulsed-field gradient spin-echo NMR experiments. DOSY is an
effective tool to analyze intermediates and to discriminate differ-
ent species in solution [14,26–28]. The aligned triazole proton,
phenyl proton and ester methyl proton resonances shown in 1H
DOSY spectra of 2 (Fig. 3a) indicate all these nuclei are from a sin-
gle species in solution. These two sets of aligned triazole proton,
phenyl proton and ester methyl proton resonances shown in the
DOSY spectra of the mixture of free 1,4-triazole ligand and 2
(Fig. 3b) correspond to free and coordinated ligands, respectively.
tained at the bottom of the vial. Crystal data: CCDC 832826,
ꢀ
Zn2C46O8N14H30
b = 9.4324(19) Å, c = 15.273(3) Å,
= 69.63(3). Z = 1, V = 1110.0(4) Å3,
,
M = 1037.58, Triclinic, P1, a = 8.3381(17) Å,
a
= 80.33(3), b = 87.11(3),
values: (I > 2 (I))
c
R
r
R1 = 0.0950, wR2 = 0.2665; GOF = 0.902. Yield: 164 mg, 63.1%. IR
(DMSO, 2500–1400 cmÀ1): 2122.72, 1700.53, 1618.15, 1601.68,
1568.50, 1501.35, 1460.39 cmÀ1
.
1H NMR (DMSO-d6, 300 MHz): d
These aligned peaks exhibiting a faster diffusion coefficient
8.908 (d, J = 3.12 Hz), 8.37(d, J = 8.16 Hz), 8.04(s), 8.005 (d,
J = 3.66 Hz), 7.96 (d, J = 8.04 Hz), 7.77 (t, J = 7.5 Hz), 7.61(t,
J = 7.5 Hz), 7.54 (q, J = 4.1 Hz), 7.14 (d, J = 8.16 Hz).
(LogD ꢁ À8.15 m2/s) correspond to free ligand (L) and the aligned
peaks exhibiting a slower diffusion coefficient (LogD ꢁ À8.72 m2/
s) correspond to the coordinated ligand (L). The comparison be-
tween DOSY spectra in Fig. 3a and b clearly indicates that the inter-
mediate compound-2 exists in the coordinated form in solution.
Although the exact molecular structure of 2 cannot be derived
Zn(OOC–C6H4–C2HN3–COOCH3)2 (2): Complex
260 mg) and 90 l methyl propiolate (1 mmol) were suspended in
10 ml mixture solution of water and t-butanol (v:v = 1:1) in a round
1 (0.25 mmol,
l